Russian scientists have produced the first three test batches of a newly developed cancer vaccine at the Gamaleya Institute ...

The U.S. is in "big danger" of falling behind in vaccine technology research as government funding declines and vaccine ...

Manufacturing plan aligns with the African Union’s ambition to produce 60 per cent of the continent’s vaccine needs by 2040.

Stanford Medicine investigators have unearthed the biological process by which mRNA-based vaccines for COVID-19 can cause heart damage in some young men and adolescents - and they've shown a possible ...

A new study identifies a mechanism for how COVID vaccines may, in infrequent cases, drive heart inflammation, a condition ...

Stanford Medicine investigators have unearthed the biological process by which mRNA-based vaccines for COVID-19 can cause ...

Study points to source of "very, very rare" cases of myocarditis and potential solutions. Myocarditis risk remains far higher ...

A rapid, two-step immune reaction may underlie rare cases of heart inflammation seen after Covid mRNA vaccination, Stanford ...

The Food and Drug Administration is investigating whether COVID-19 vaccines caused deaths in adults, as part of a safety ...

An internal memo written by the Food and Drug Administration’s top vaccine regulator offers a concerning glimpse into the ...

MOSCOW, December 9. /TASS/. The first three test series of the mRNA anti-cancer vaccine have been manufactured in Russia, Alexander Gintsburg, Director of the Gamaleya National Research Center for ...

An internal memo written by the Food and Drug Administration’s top vaccine regulator offers a concerning glimpse into the future of vaccine regulation in the US — and could have profound implications ...